HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erythrocyte, platelet and polymorphonuclear leukocyte membrane dynamic properties in essential hypertension.

Abstract
In subjects with essential hypertension we evaluated, respectively, the red cell membrane protein lateral mobility (obtained marking intact red blood cells with pyrene-3-maleimide (3-PM)), the erythrocyte membrane fluidity (obtained marking intact erythrocytes with 10-(1-pyrene) decanoic acid), the red cell membrane transverse fluidity gradient (obtained marking intact red blood cells with a set of fatty acid fluorescent probes (2-AP, 6-AS, 9-AS, 12-AS)), the platelet membrane fluidity (obtained marking intact and unstimulated platelets with 1,6-diphenyl-1,3,5-hexatriene (DPH) and with 1-(4-(trimethylamino)phenyl)-6-phenyl-1,3,5-hexatriene (TMA-DPH)) and the polymorphonuclear membrane fluidity (obtained marking intact and unstimulated polymorphonuclear cells with TMA-DPH). From the obtained data it is evident that: (1) red cell membrane protein lateral mobility does not distinguish normals from hypertensives; (2) erythrocyte membrane fluidity and red cell membrane transverse fluidity gradient clearly discriminate normals from hypertensives; (3) platelet membrane fluidity differentiates normals from hypertensives only when DPH is used as fluorescent probe; (4) polymorphonuclear membrane fluidity does not distinguish normals from hypertensives. Our results show that in essential hypertension a different behaviour of the membrane dynamic properties in the circulating blood cells is evident.
AuthorsG Caimi
JournalClinical hemorheology and microcirculation (Clin Hemorheol Microcirc) 1997 May-Jun Vol. 17 Issue 3 Pg. 199-208 ISSN: 1386-0291 [Print] Netherlands
PMID9356784 (Publication Type: Clinical Trial, Journal Article)
Topics
  • Adult
  • Blood Platelets (physiology)
  • Erythrocyte Membrane (physiology)
  • Female
  • Fluorescence Polarization
  • Humans
  • Hypertension (blood)
  • Male
  • Membrane Fluidity (physiology)
  • Middle Aged
  • Neutrophils (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: